Fortress Biotech, Inc. FBIOP
Set alert
At close
Pre-market · Nov 2, 8:27 AM ET
- YTD
- +59.11%
- 1 year
- +120.12%
- Open
- 15.39
- Prev close
- 15.59
- Mkt cap
- 62.20M
- Vol
- 24.34K
- Avg vol
- 12.54K
- EPS
- -0.863
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 15.05
- High
- 15.76
- Forward P/E
- 0.00
- Beta
- 1.75
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 2.34
- Ex-div date
- Jun 13, 2024
- 50-d avg
- 5.83
- 200-d avg
- 10.33
- 1y target
- 0.00
MAX chart
Events in this range
- Dec 14, 2017Dividend: 0.29948
- Mar 14, 2018Dividend: 0.586
- Jun 14, 2018Dividend: 0.586
- Sep 13, 2018Dividend: 0.586
- Dec 13, 2018Dividend: 0.586
- Mar 14, 2019Dividend: 0.586
- Jun 13, 2019Dividend: 0.586
- Sep 12, 2019Dividend: 0.586
- Dec 12, 2019Dividend: 0.586
- Mar 13, 2020Dividend: 0.586
- Jun 12, 2020Dividend: 0.586
- Jul 17, 2020Dividend: 0.195
- Aug 20, 2020Dividend: 0.195
- Sep 14, 2020Dividend: 0.195
- Oct 14, 2020Dividend: 0.195
- Nov 12, 2020Dividend: 0.195
- Dec 14, 2020Dividend: 0.195
- Jan 14, 2021Dividend: 0.195
- Feb 11, 2021Dividend: 0.195
- Mar 12, 2021Dividend: 0.195
- Apr 14, 2021Dividend: 0.195
- May 13, 2021Dividend: 0.195
- Jun 14, 2021Dividend: 0.195
- Jul 14, 2021Dividend: 0.195
- Aug 12, 2021Dividend: 0.195
- Sep 14, 2021Dividend: 0.195
- Oct 14, 2021Dividend: 0.195
- Nov 12, 2021Dividend: 0.195
- Dec 14, 2021Dividend: 0.195
- Jan 13, 2022Dividend: 0.195
- Feb 14, 2022Dividend: 0.195
- Mar 14, 2022Dividend: 0.19531
- Apr 13, 2022Dividend: 0.195
- May 12, 2022Dividend: 0.195
- Jun 14, 2022Dividend: 0.195
- Jul 14, 2022Dividend: 0.195
- Aug 12, 2022Dividend: 0.19531
- Sep 14, 2022Dividend: 0.195
- Oct 13, 2022Dividend: 0.195
- Nov 14, 2022Dividend: 0.195
- Dec 14, 2022Dividend: 0.195
- Jan 12, 2023Dividend: 0.195
- Feb 14, 2023Dividend: 0.19531
- Mar 14, 2023Dividend: 0.19531
- Apr 13, 2023Dividend: 0.19531
- May 12, 2023Dividend: 0.19531
- Jun 14, 2023Dividend: 0.19531
- Jul 13, 2023Dividend: 0.19531
- Aug 14, 2023Dividend: 0.19531
- Sep 14, 2023Dividend: 0.19531
- Oct 12, 2023Dividend: 0.19531
- Nov 14, 2023Dividend: 0.19531
- Dec 14, 2023Dividend: 0.19531
- Jan 11, 2024Dividend: 0.19531
- Feb 14, 2024Dividend: 0.19531
- Mar 14, 2024Dividend: 0.19531
- Apr 12, 2024Dividend: 0.19531
- May 14, 2024Dividend: 0.19531
- Jun 14, 2024Dividend: 0.19531
Signals (182)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| RSI: Overbought | May 18, 2026 | 5 months ago |
| SMA: Bullish | May 11, 2026 | 5 months ago |
| MACD: Buy Signal | May 11, 2026 | 5 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| MACD: Sell Signal | May 4, 2026 | 6 months ago |
| SMA: Bullish | Feb 23, 2026 | 8 months ago |
| RSI: Overbought | Feb 23, 2026 | 8 months ago |
| SMA: Bearish | Feb 16, 2026 | 8 months ago |
| RSI: Overbought | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Dec 15, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Dec 1, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 6, 2025 | 1 year ago |
| SMA: Bearish | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Sep 29, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | Aug 11, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 28, 2025 | 1 year ago |
| SMA: Bearish | Jul 14, 2025 | 1 year ago |
| SMA: Bullish | Apr 21, 2025 | 1 year ago |
| SMA: Bullish | Apr 21, 2025 | 1 year ago |
| SMA: Bearish | Mar 31, 2025 | 1 year ago |
| SMA: Bearish | Mar 31, 2025 | 1 year ago |
| SMA: Bullish | Mar 10, 2025 | 1 year ago |
| SMA: Bullish | Mar 10, 2025 | 1 year ago |
| SMA: Bearish | Feb 17, 2025 | 1 year ago |
| SMA: Bearish | Jan 27, 2025 | 1 year ago |
| SMA: Bullish | Jan 20, 2025 | 1 year ago |
| SMA: Bullish | Nov 25, 2024 | 1 year ago |
| RSI: Oversold | Nov 4, 2024 | 1 year ago |
| MACD: Buy Signal | Oct 28, 2024 | 2 years ago |
| RSI: Oversold | Aug 12, 2024 | 2 years ago |
| SMA: Bearish | Jul 8, 2024 | 2 years ago |
| SMA: Bearish | Jul 8, 2024 | 2 years ago |
| RSI: Oversold | Jul 8, 2024 | 2 years ago |
| SMA: Bullish | Jul 1, 2024 | 2 years ago |
| SMA: Bearish | Jun 24, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 17, 2024 | 2 years ago |
| SMA: Bullish | Jun 3, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 3, 2024 | 2 years ago |
| SMA: Bearish | May 20, 2024 | 2 years ago |
| MACD: Sell Signal | May 20, 2024 | 2 years ago |
| SMA: Bullish | May 13, 2024 | 2 years ago |
| SMA: Bearish | Apr 15, 2024 | 2 years ago |
| SMA: Bullish | Jan 29, 2024 | 2 years ago |
| SMA: Bearish | Jan 22, 2024 | 2 years ago |
| SMA: Bullish | Jan 8, 2024 | 2 years ago |
| SMA: Bearish | Dec 11, 2023 | 2 years ago |
| SMA: Bullish | Dec 4, 2023 | 2 years ago |
| SMA: Bullish | Nov 20, 2023 | 2 years ago |
| SMA: Bearish | Nov 13, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 13, 2023 | 2 years ago |
| SMA: Bullish | Nov 6, 2023 | 2 years ago |
| MACD: Sell Signal | Aug 14, 2023 | 3 years ago |
| RSI: Oversold | Aug 14, 2023 | 3 years ago |
| SMA: Bearish | Aug 7, 2023 | 3 years ago |
| SMA: Bullish | Jul 31, 2023 | 3 years ago |
| SMA: Bearish | Jul 24, 2023 | 3 years ago |
| SMA: Bullish | Jul 17, 2023 | 3 years ago |
| MACD: Buy Signal | Jul 17, 2023 | 3 years ago |
| SMA: Bearish | Jul 10, 2023 | 3 years ago |
| SMA: Bullish | Jul 3, 2023 | 3 years ago |
| RSI: Oversold | May 29, 2023 | 3 years ago |
| SMA: Bearish | May 15, 2023 | 3 years ago |
| SMA: Bullish | May 8, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 27, 2023 | 3 years ago |
| SMA: Bearish | Mar 13, 2023 | 3 years ago |
| SMA: Bearish | Mar 13, 2023 | 3 years ago |
| SMA: Bullish | Feb 27, 2023 | 3 years ago |
| SMA: Bearish | Feb 20, 2023 | 3 years ago |
| SMA: Bullish | Jan 30, 2023 | 3 years ago |
| SMA: Bullish | Jan 23, 2023 | 3 years ago |
| SMA: Bearish | Jan 16, 2023 | 3 years ago |
| SMA: Bearish | Jan 16, 2023 | 3 years ago |
| SMA: Bullish | Jan 9, 2023 | 3 years ago |
| SMA: Bullish | Jan 9, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 9, 2023 | 3 years ago |
| MACD: Sell Signal | Dec 26, 2022 | 3 years ago |
| SMA: Bearish | Dec 19, 2022 | 3 years ago |
| SMA: Bearish | Dec 12, 2022 | 3 years ago |
| SMA: Bullish | Oct 31, 2022 | 4 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| SMA: Bearish | Oct 10, 2022 | 4 years ago |
| SMA: Bullish | Oct 3, 2022 | 4 years ago |
| SMA: Bearish | Aug 29, 2022 | 4 years ago |
| SMA: Bearish | Aug 15, 2022 | 4 years ago |
| SMA: Bullish | Aug 8, 2022 | 4 years ago |
| MACD: Buy Signal | Aug 1, 2022 | 4 years ago |
| SMA: Bullish | Jul 18, 2022 | 4 years ago |
| RSI: Oversold | May 16, 2022 | 4 years ago |
| SMA: Bearish | Apr 18, 2022 | 4 years ago |
| SMA: Bullish | Mar 28, 2022 | 4 years ago |
| RSI: Oversold | Feb 28, 2022 | 4 years ago |
| SMA: Bearish | Jan 24, 2022 | 4 years ago |
| SMA: Bearish | Jan 24, 2022 | 4 years ago |
| SMA: Bullish | Jan 3, 2022 | 4 years ago |
| SMA: Bullish | Jan 3, 2022 | 4 years ago |
| SMA: Bearish | Dec 27, 2021 | 4 years ago |
| SMA: Bearish | Dec 27, 2021 | 4 years ago |
| SMA: Bullish | Dec 20, 2021 | 4 years ago |
| SMA: Bullish | Dec 20, 2021 | 4 years ago |
| SMA: Bearish | Dec 13, 2021 | 4 years ago |
| SMA: Bearish | Dec 13, 2021 | 4 years ago |
| SMA: Bullish | Nov 29, 2021 | 4 years ago |
| SMA: Bullish | Nov 29, 2021 | 4 years ago |
| SMA: Bearish | Nov 22, 2021 | 4 years ago |
| SMA: Bullish | Oct 4, 2021 | 5 years ago |
| SMA: Bearish | Aug 9, 2021 | 5 years ago |
| SMA: Bullish | Jul 26, 2021 | 5 years ago |
| SMA: Bearish | Jul 19, 2021 | 5 years ago |
| RSI: Overbought | Jun 28, 2021 | 5 years ago |
| SMA: Bullish | Jun 21, 2021 | 5 years ago |
| SMA: Bearish | Jun 14, 2021 | 5 years ago |
| MACD: Sell Signal | Jun 14, 2021 | 5 years ago |
| RSI: Overbought | Apr 5, 2021 | 5 years ago |
| RSI: Overbought | Mar 22, 2021 | 5 years ago |
| SMA: Bullish | Mar 8, 2021 | 5 years ago |
| SMA: Bearish | Mar 1, 2021 | 5 years ago |
| RSI: Overbought | Feb 1, 2021 | 5 years ago |
| MACD: Buy Signal | Nov 16, 2020 | 5 years ago |
| SMA: Bullish | Nov 9, 2020 | 5 years ago |
| SMA: Bullish | Nov 9, 2020 | 5 years ago |
| MACD: Sell Signal | Oct 26, 2020 | 6 years ago |
| SMA: Bearish | Oct 19, 2020 | 6 years ago |
| SMA: Bearish | Oct 12, 2020 | 6 years ago |
| SMA: Bullish | Sep 28, 2020 | 6 years ago |
| SMA: Bearish | Sep 21, 2020 | 6 years ago |
| SMA: Bullish | Aug 10, 2020 | 6 years ago |
| SMA: Bullish | Aug 3, 2020 | 6 years ago |
| SMA: Bearish | Jun 22, 2020 | 6 years ago |
| MACD: Buy Signal | May 4, 2020 | 6 years ago |
| SMA: Bullish | Apr 20, 2020 | 6 years ago |
| RSI: Oversold | Mar 9, 2020 | 6 years ago |
| MACD: Sell Signal | Feb 17, 2020 | 6 years ago |
| SMA: Bearish | Feb 10, 2020 | 6 years ago |
| SMA: Bearish | Feb 10, 2020 | 6 years ago |
| SMA: Bullish | Feb 3, 2020 | 6 years ago |
| SMA: Bullish | Feb 3, 2020 | 6 years ago |
| MACD: Buy Signal | Feb 3, 2020 | 6 years ago |
| SMA: Bearish | Jan 27, 2020 | 6 years ago |
| SMA: Bearish | Jan 27, 2020 | 6 years ago |
| MACD: Sell Signal | Jan 27, 2020 | 6 years ago |
| SMA: Bullish | Jan 13, 2020 | 6 years ago |
| MACD: Buy Signal | Jan 13, 2020 | 6 years ago |
| SMA: Bullish | Dec 30, 2019 | 6 years ago |
| SMA: Bearish | Nov 18, 2019 | 6 years ago |
| SMA: Bearish | Nov 18, 2019 | 6 years ago |
| SMA: Bullish | Oct 14, 2019 | 7 years ago |
| SMA: Bullish | Sep 30, 2019 | 7 years ago |
| SMA: Bearish | Sep 9, 2019 | 7 years ago |
| SMA: Bearish | Aug 19, 2019 | 7 years ago |
| MACD: Sell Signal | Aug 19, 2019 | 7 years ago |
| SMA: Bullish | Apr 15, 2019 | 7 years ago |
| SMA: Bearish | Apr 1, 2019 | 7 years ago |
| SMA: Bullish | Jan 28, 2019 | 7 years ago |
| MACD: Buy Signal | Jan 7, 2019 | 7 years ago |
| SMA: Bullish | Dec 31, 2018 | 7 years ago |
| MACD: Sell Signal | Dec 17, 2018 | 7 years ago |
| SMA: Bearish | Dec 10, 2018 | 7 years ago |
| MACD: Buy Signal | Nov 26, 2018 | 7 years ago |
| SMA: Bullish | Nov 19, 2018 | 7 years ago |
| RSI: Oversold | Oct 22, 2018 | 8 years ago |
| SMA: Bearish | Oct 8, 2018 | 8 years ago |
| SMA: Bullish | Oct 1, 2018 | 8 years ago |
| SMA: Bearish | Sep 17, 2018 | 8 years ago |
| SMA: Bullish | Sep 10, 2018 | 8 years ago |
| RSI: Oversold | Jul 30, 2018 | 8 years ago |
| SMA: Bearish | May 21, 2018 | 8 years ago |
| SMA: Bullish | May 14, 2018 | 8 years ago |
| SMA: Bearish | Apr 2, 2018 | 8 years ago |
| SMA: Bullish | Mar 26, 2018 | 8 years ago |
| SMA: Bearish | Mar 19, 2018 | 8 years ago |
| SMA: Bullish | Mar 12, 2018 | 8 years ago |
| SMA: Bearish | Mar 5, 2018 | 8 years ago |
| SMA: Bullish | Feb 19, 2018 | 8 years ago |
Key statistics
- Market cap
- 35.16M
- Enterprise value
- 96.10M
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.43
- Price / book
- 4.39
- EPS (TTM)
- -0.863
- Beta
- 1.75
- Dividend yield
- 45.96%
- Payout ratio
- 0.00%
- Profit margin
- -49.25%
- Revenue (TTM)
- 82.62M
- Revenue growth
- -14.30%
- Free cash flow
- -59.20M
- Total cash
- 76.20M
- Total debt
- 88.42M
- Return on equity
- 0.00%
- Shares outstanding
- 56.68M
- Short % of float
- 0.00%
- 50-day average
- 5.83
- 200-day average
- 10.33
Analyst view
Consensus: none
Next earnings
Consensus EPS estimate 0.00.
About Fortress Biotech, Inc.
Fortress Biotech, Inc., a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet. It also develops late stage product candidates, such as intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for the treatment of Menkes disease; Cosibelimab for metastatic cancers; Olafertinib for the treatment of patients with EGFR mutation-positive NSCLC; CAEL-101 for the treatment of amyloid light chain amyloidosis; Triplex vaccine for cytomegalovirus; and DFD-29 for the treatment of rosacea. The company's early stage product candidates include Dotinurad for gout; MB-106 for B-cell non-hodgkin lymphoma; MB-101 for glioblastoma; MB-108 for recurrent GBM; MB-109 for refractory glioblastoma; AJ201, an androgen receptor degradation enhancer; BAER-101, a positive allosteric modulator; MB-117 for newly diagnosed x-linked severe combined immunodeficiency; and MB217 for previously transplanted; and MB-110 for RAG1 severe combined immunodeficiency. Its preclinical product candidates comprise Mayo Clinic In Vivo CAR T Platform Technology; AAV-ATP7A gene therapy; AVTS-001 gene therapy; CK-103 BET inhibitor; CEVA-D and CEVA-102; CK-302, an anti-GITR; CK-303, an anti-CAIX; and oligonucleotide platform. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Islands, Florida.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- fortressbiotech.com
News
- 12 Health Care Stocks Moving In Monday's Intraday Session
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- 12 Health Care Stocks Moving In Friday's After-Market Session
- Stocks Which Set New 52-Week Low Yesterday, October 22nd
- Stocks Which Set New 52-Week Low Yesterday, August 2nd
Your note
Sign in to keep a note on FBIOP — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| JIN DAVID | Chief Financial Officer | Purchase | Jul 9, 2024 | 500 |
| ROSENWALD LINDSAY A | Chief Executive Officer | Purchase | Jul 10, 2024 | 127,500 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Shikiar Asset Management, Inc. | 0.44% | 15,000 | 98.25K | Jun 29, 2023 |